Abstract
Experimental evidence has suggested that the high endogenous levels of taurine found in the rat heart and retina are maintained to a large extent by transport processes out of the blood, rather than by endogenous biosynthesis. When these high levels are depleted, dysfunction ensues. In vitro studies have shown that β-alanine is a good antagonist of these transport processes. The current studies were done to evaluate the feasibility of depleting heart and retinal taurine levels in vivo through treatment of adult rats either orally or with injections of β-alanine. None of the treatments had significant effects on retinal taurine content; ventricular taurine was reduced in some situations, but the effects were not maintained, nor as large as with another transport antagonist. No functional changes were observed. Oral treatment with β-alanine had fewer obvious side effects than injections, but all treated rats had body weights less than age-matched controls.
Similar content being viewed by others
References
Lake, N. 1986. Electroretinographic deficits in rats treated with guanidinoethyl sulfonate, a depletor of taurine. Exp. Eye Res. 42:87–91.
Lake, N., and Malik, N. 1987. Retinal morphology in rats treated with a taurine transport antagonist. Exp. Eye Res. 44:331–346.
Hayes, K. C., Carey, R. E., and Schmidt, S. Y. 1975. Retinal degeneration associated with taurine deficiency in the cat. Science 188:949–951.
Neuringer, M. D., Sturman, J. A., Wen, G. Y., and Wisniewski, H. M. 1985. Dietary taurine is necessary for normal retinal development in monkeys. Pages 53–62,in Oja, S. S., Ahtee, L., Kontro, P., and Paasonen, M. K. (eds.), Taurine: Biological Actions and Clinical Perspectives, Alan R. Liss, New York.
Geggel, S. H., Ament, H. E., Heckenlively, J. R., Martin, D. A., and Kopple, J. D. 1985. Nutritional requirement for taurine in patients receiving long-term parenteral nutrition. New Engl. J. Med. 312:142–146.
Lake, N., De Roode, M., and Nattel, S. 1987. Effects of taurine depletion on rat cardiac electrophysiology: in vivo and in vitro studies. Life Sciences 40:997–1005.
Pion, P. D., Kittleson, M. D., Rogers, Q. R., and Morris, J. G. 1987. Myocardial failure in cats associated with low plasma taurine: a reversible cardiomyopathy. Science 237:764–768.
Huxtable, R. J. 1976. Metabolism and function of taurine in the heart. Pages 99–119,in Huxtable, R., and Barbeau, A. (eds.), Taurine, Raven Press, New York.
Lake, N. 1981. Depletion of retinal taurine by treatment with guanidinoethyl sulfonate. Life Sciences 29:445–448.
Lake, N. 1982. Depletion of taurine in the adult rat retina. Neurochem. Res. 7:1385–1390.
Sturman, J. A., and Hayes, K. C. 1980. The biology of taurine in nutrition and development. Adv. Nutr. Res. 3:231–299.
Huxtable, R. J., Laird, H. E., and Lippincott, S. 1979. The transport of taurine in the heart and rapid depletion of tissue taurine content by guanidinoethyl sulfonate. J. Pharmacol. Exp. Ther. 211:465–471.
Yates, C., Dewar, A., Wilson, H., Winterburn, A., and Reading, H. 1974. Histological and biochemical studies on the retina of a new strain of dystrophic rat. Exp. Eye Res. 18:119–133.
Troll, W., and Cannan, R. 1953, A modified photometric ninhydrin method for the analysis of amino and imino acids. J. Biol. Chem. 200:803–811.
Larsen, B. R., Grosso, D. S., and Chang, S. Y. 1980. A rapid method for taurine quantitation using high performance liquid chromatography. J. Chromatographic Science 18:233–236.
Starr, M. S., and Voaden, M. J. 1972. The uptake metabolism and release of14C-taurine by rat retina in vitro. Vis. Res. 12:1261–1269.
Shaffer, J. E., and Kocsis, J. J. 1981. Methods of reducing tissue taurine levels. Pages 219–229,in Schaffer, S. W., Baskin, S. I., and Kocsis J. J. (eds.), The Effects of Taurine on Excitable Tissues, Spectrum Publications, New York.
Pasantes-Morales, H., Quesada, O., Carabez, A., and Huxtable, R. J. 1983. Effects of the taurine transport antagonist, guanidinoethane sulfonate, and β-alanine on the morphology of rat retina. J. Neurosci. Res. 9:135–143.